301301 Stock Overview
Yili Chuanning Biotechnology Co.,Ltd. engages in the research and development, and industrialization of biological fermentation technology in China.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Yili Chuanning Biotechnology Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.98 |
| 52 Week High | CN¥10.99 |
| 52 Week Low | CN¥6.94 |
| Beta | 0 |
| 1 Month Change | 19.35% |
| 3 Month Change | 34.23% |
| 1 Year Change | 14.85% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 9.25% |
Recent News & Updates
Shareholder Returns
| 301301 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 16.9% | 2.5% | 2.2% |
| 1Y | 14.9% | -24.0% | -14.2% |
Return vs Industry: 301301 exceeded the CN Biotechs industry which returned -24% over the past year.
Return vs Market: 301301 exceeded the CN Market which returned -14.2% over the past year.
Price Volatility
| 301301 volatility | |
|---|---|
| 301301 Average Weekly Movement | 7.4% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 301301's share price has been volatile over the past 3 months.
Volatility Over Time: 301301's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 2,881 | Xuheng Deng | www.klcnsw.com |
Yili Chuanning Biotechnology Co.,Ltd. engages in the research and development, and industrialization of biological fermentation technology in China. It offers antibiotic intermediates, such as erythromycin thiocyanate, penicillin G potassium salt, 6-aminopenicillanic acid, 7-aminocephalosporanic acid, 7-aminodesacetoxycephalosporanic acid, desacetyl-7-aminocephalosporanic acid, and ursodeoxycholic acid.
Yili Chuanning Biotechnology Co.,Ltd. Fundamentals Summary
| 301301 fundamental statistics | |
|---|---|
| Market cap | CN¥24.41b |
| Earnings (TTM) | CN¥1.12b |
| Revenue (TTM) | CN¥5.08b |
21.8x
P/E Ratio4.8x
P/S RatioIs 301301 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301301 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.08b |
| Cost of Revenue | CN¥3.40b |
| Gross Profit | CN¥1.67b |
| Other Expenses | CN¥554.71m |
| Earnings | CN¥1.12b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.50 |
| Gross Margin | 32.94% |
| Net Profit Margin | 22.02% |
| Debt/Equity Ratio | 23.4% |
How did 301301 perform over the long term?
See historical performance and comparison